Newbury Pharmaceuticals AB (OSTO:NEWBRY) Net Margin % : -158.25% (As of Feb. 2024)

Newbury Pharmaceuticals AB Net Margin % Chart

Newbury Pharmaceuticals AB Quarterly Data
	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Net Margin %	Get a 7-Day Free Trial									-322.58	-72.08	-168.16	-31.51	-158.25

Competitive Comparison of Newbury Pharmaceuticals AB's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Newbury Pharmaceuticals AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Newbury Pharmaceuticals AB's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Newbury Pharmaceuticals AB's Net Margin % distribution charts can be found below:

* The bar in red indicates where Newbury Pharmaceuticals AB's Net Margin % falls into.

Newbury Pharmaceuticals AB Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Newbury Pharmaceuticals AB's Net Margin for the fiscal year that ended in Aug. 2023 is calculated as

Newbury Pharmaceuticals AB's Net Margin for the quarter that ended in Feb. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Newbury Pharmaceuticals AB  (OSTO:NEWBRY) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Newbury Pharmaceuticals AB Net Margin % Related Terms

Thank you for viewing the detailed overview of Newbury Pharmaceuticals AB's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Newbury Pharmaceuticals AB (OSTO:NEWBRY) Business Description